This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions

Example MedicationDispense/meddisp0315 (Narrative)

Pharmacy Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Encounter, Patient, Practitioner

This is the narrative for the resource. See also the XML, JSON or Turtle format.

Generated Narrative: MedicationDispense

Resource MedicationDispense "meddisp0315"

status: in-progress



code: amylase / cellulase / hyoscyamine / lipase / phenyltoloxamine / protease Oral Capsule (RxNorm#562721)

subject: Patient/pat1: Donald Duck "Donald DUCK"


*Practitioner/f006 "Rob VAN DEN BERK"

authorizingPrescription: MedicationRequest/medrx0305

type: Refill - Part Fill (ActCode#RFP)

quantity: 30(unit TAB from http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm) (Details: http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm code TAB = 'Tablet')

daysSupply: 10 Day (Details: UCUM code d = 'd')

whenPrepared: 2015-06-25T07:13:00+05:00

whenHandedOver: 2015-06-26T07:13:00+05:00


sequence: 1

text: 0.25mg PO every 6-12 hours as needed for menses from Jan 15-20, 2015. Do not exceed more than 4mg per day

additionalInstruction: Warning. May cause drowsiness. If affected do not drive or operate machinery. Avoid alcoholic drink (qualifier value) (SNOMED CT#418914006)

timing: Starting 2015-01-15, Once per 6-12 hours, Until 2015-01-20

asNeededFor: Dysmenorrhea (disorder) (SNOMED CT#266599000)

route: Oral Route (SNOMED CT#26643006)


Generated Narrative: Medication #med0314

code: amylase / cellulase / hyoscyamine / lipase / phenyltoloxamine / protease Oral Capsule (RxNorm#562721)



Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.